Linden Capital Partners Acquires LifeStyles Healthcare
December 1, 2022
Linden Capital Partners has acquired LifeStyles Healthcare, a global sexual health and wellness platform, from a consortium of investors including Trustar Capital and Humanwell Healthcare. The deal excludes LifeStyles' Chinese operations (including the Jissbon brand), which will be retained by the selling shareholders; Linden has named Laurent Faracci as incoming CEO and Ron Fugate as Chairman to drive commercial, brand, and innovation-led growth.
- Buyers
- Linden Capital Partners
- Targets
- LifeStyles Healthcare
- Sellers
- Trustar Capital, Humanwell Healthcare, Consortium of investors
- Industry
- Consumer Products
- Location
- New York, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Linden Capital Partners Takes Majority Stake in Vital Care
October 19, 2020
Healthcare Services
Linden Capital Partners, a Chicago-based healthcare private equity firm, announced a majority investment in Vital Care, Inc., the Meridian, Mississippi franchisor of home infusion services. The transaction was completed alongside current shareholders (the Bell family) and management, with Linden positioning to support growth of the franchise system through healthcare-focused operating expertise and capital.
-
Healthly Acquires Lifestyle Medical (Non-Clinical Assets)
June 13, 2024
Healthcare Services
Healthly announced the acquisition of Lifestyle Medical's non-clinical assets and a management services partnership to operate the practice's non-clinical operations. Lifestyle Medical, a lifestyle-medicine primary care practice founded in 2015 with two Southern California locations, will provide clinical leadership while Healthly integrates the clinic model into its Medicare Advantage membership-based care.
-
Linden Capital Partners Acquires Alcresta Therapeutics
March 12, 2024
Medical Devices
Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.
-
Linden Capital Partners Makes Majority Investment in Aptitude Health
April 26, 2021
Healthcare Services
Linden Capital Partners will make a majority investment in Aptitude Health alongside the company's founder and management team. Aptitude Health, an Atlanta-based provider of market insights and strategic solutions for oncology and hematology, will partner with Linden to accelerate growth and expand its service offerings; the transaction was expected to close in May 2021.
-
Linden Capital Partners Acquires Majority Stake in Specialty Networks
December 15, 2020
Healthcare Services
Linden Capital Partners, a Chicago-based healthcare private equity firm, made a majority investment in Specialty Networks, LLC alongside current shareholders including Nautic Partners and management. The investment will provide Specialty Networks — a Rocky River, Ohio-based provider of a urology-focused GPO, analytics, and consulting services — with capital and resources to expand its services and capabilities for community-based urology practices and industry partners.
-
Berkshire Partners and Leonard Green Join Linden in Strategic Investment in Vital Care
August 1, 2024
Healthcare Services
Vital Care, a Brentwood, Tennessee-based franchisor of infusion therapy pharmacies with more than 160 locations, received a strategic investment from Berkshire Partners and Leonard Green & Partners alongside existing investor Linden Capital Partners. The capital will support franchisee reinvestment, operational enhancements, and continued expansion to increase access to infusion therapy across the U.S.; financial terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.